Issue 43, 2020

From structure to crystallisation and pharmaceutical manufacturing: the CSD in CMAC workflows

Abstract

Two workflows are presented that are relevant to the design and construction of end-to-end pharmaceutical manufacturing processes. The workflows target the very early stage crystallisation aspect of these processes – production of the primary crystalline solid form – and relate to establishing decision-driven approaches for the screening for multi-component forms, specifically co-crystals, and to the use of additives to control crystal and primary particle form, notably morphology. These workflows are shown to benefit from the use of the million-plus structures in the Cambridge structural database and the associated structural informatics and analysis tools and are placed into the context of the work of the CMAC Future Manufacturing Hub.

Graphical abstract: From structure to crystallisation and pharmaceutical manufacturing: the CSD in CMAC workflows

Supplementary files

Article information

Article type
Paper
Submitted
23 juin 2020
Accepted
15 sept. 2020
First published
22 sept. 2020
This article is Open Access
Creative Commons BY license

CrystEngComm, 2020,22, 7475-7489

From structure to crystallisation and pharmaceutical manufacturing: the CSD in CMAC workflows

L. E. Hatcher, A. J. Burgess, P. Payne and C. C. Wilson, CrystEngComm, 2020, 22, 7475 DOI: 10.1039/D0CE00898B

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements